Yes, they can temporarily disrupt the gut microbiome
"It was particularly interesting to learn what lasting impacts a GLP-1 medication may have on consumers they continue to try to maintain those healthy eating habits even as the 'food noise' returns." "As a result of the study, we have identified key implications for brands and retailers regarding product prioritizations and how we can best convey product benefits to support weight loss journeys, both during and post GLP-1 therapy," said Jami McDermid, president, CROSSMARK Sales Agency, a division of Acosta Group
Outcomes of a family based pediatric obesity programpreliminary results
Primary Handling Editor: George Caputa
Unintentional weight loss : Beyond expected therapeutic weight reduction, or inability to maintain adequate nutrition
Osteopenia in women with hypothalamic amenorrhea: a prospective study